Addressing Gaps for Women With HIV Involved in the Criminal Justice System

Jaimie P. Meyer, MD, from the Yale School of Medicine, discusses her work on identifying opportunities to reduce risk for HIV transmission, particularly in women ...

Treating and Preventing HIV With Generic Drugs

Generic antiretroviral agents have had a dramatic effect on outcomes in developing nations, and their availability in developed countries is rapidly expanding as more brand-name ...

Treating Major Depressive Disorder Improves Outcomes in HIV

Mental health problems are 1 of the most important reasons for failing to engage in long-term control of HIV.

Improving Adherence to ART in HIV

The rapidly developing landscape of antiretroviral therapy adherence monitoring has great potential for clinical application, but cost-effectiveness and feasibility studies are needed to define the ...

Preventing HIV, STIs Through School-Based Programs

Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based ...

PrEP Crucial for People Involved in Criminal Justice Systems

Important strategies to consider for people involved in the criminal justice systems include linkage to antiretroviral therapy for those who are HIV positive and linkage ...

Pausing ART: Safety and Ethical Considerations

Dr Gianella Weibel talks with Dr Li and Dr Dubé, investigators of a new study from the AIDS Clinical Trials Group, which uses an intensively ...
HIV/AIDS

Latest News

Barriers to Prevention, Eradication of HIV Remain Despite Numerous Advances

Barriers to Prevention, Eradication of HIV Remain Despite Numerous Advances

Since the first clinical observation of HIV/AIDS in 1981, some 35.4 million people have died from AIDS-related illnesses.

Biologic Agents Used to Treat Patients With Psoriasis and HIV Infection

Biologic Agents Used to Treat Patients With Psoriasis and HIV Infection

Investigators evaluated the safety and effectiveness of conventional therapy with biologic immunosuppressive drugs to treat patients with HIV infection and psoriasis.

Elevated PCSK9 Levels Associated With Coronary Endothelial Dysfunction in PLWHIV

Elevated PCSK9 Levels Associated With Coronary Endothelial Dysfunction in PLWHIV

Increased proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in people with HIV may be related to abnormal coronary endothelial function.

Lamivudine/Tenofovir Disoproxil Approved for the Treatment of HIV-1 Infection

Lamivudine/Tenofovir Disoproxil Approved for the Treatment of HIV-1 Infection

The FDA has approved Temixys tablets for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in patients weighing ≥35kg.

Increased Risk of Meningococcal Disease in Men Who Have Sex With Men

Increased Risk of Meningococcal Disease in Men Who Have Sex With Men

Men who have sex with men have an increased risk of meningococcal disease, however, this risk is under-ascertained and improved surveillance is needed.

USPSTF Suggests Universal HIV Screening, PrEP for High-Risk Patients

USPSTF Suggests Universal HIV Screening, PrEP for High-Risk Patients

Screening recommended for those ages 15 to 65 years, including pregnant women.

Increased Risk for First and Second Primary Cancers in Patients With HIV/AIDS

Increased Risk for First and Second Primary Cancers in Patients With HIV/AIDS

Increased cancer prevention, screening, and treatment are needed for people living with HIV both before and after an initial cancer diagnosis.

New Single-Vial Formulation of Tesamorelin Approved to Treat Excess HIV-Related VAT

New Single-Vial Formulation of Tesamorelin Approved to Treat Excess HIV-Related VAT

The new "F4" formulation is 4 times more concentrated than the version currently available on the market.

ART Initiated Pre-Pregnancy Lowers Hospitalization due to Infection in HIV-Exposed Infants

ART Initiated Pre-Pregnancy Lowers Hospitalization due to Infection in HIV-Exposed Infants

ART prior to becoming pregnant was linked with reduced risk for hospitalization because of infections in seronegative infants who are exposed to HIV.

Earlier Intervention May Have Lessened HIV Outbreak in Indiana

Earlier Intervention May Have Lessened HIV Outbreak in Indiana

Ensuring access to HIV services and harm-reduction interventions earlier could substantially reduce HIV incidence over the course of an actual outbreak.

Feature Article

Insight Into the HIV Self-Testing Debate

Insight Into the HIV Self-Testing Debate

Although the CDC recommends routine HIV screening for all people age 13-64 years, numerous barriers to HIV testing in healthcare settings have been identified, including lack of access and fear of stigma and discrimination.

Telling Children Their HIV Status: Interview With Dr Elizabeth Lowenthal

Telling Children Their HIV Status: Interview With Dr Elizabeth Lowenthal

Infectious Disease Advisor speaks with Elizabeth D. Lowenthal, MD, about the challenges associated with revealing HIV seropositive status to children.

Psychosocial Interventions in HIV: How Best to Support HIV-Positive Patients

Psychosocial Interventions in HIV: How Best to Support HIV-Positive Patients

Mental health professionals supporting patients living with HIV need to make space for their patients to process the emotional effect of their diagnosis, but not to make assumptions about what it means to them.

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.

How HIV Affects Cervical Cancer Risk and Outcomes

How HIV Affects Cervical Cancer Risk and Outcomes

Women with HIV have an increased risk for persistent HPV infection, which frequently progresses to cervical cancer, and they should be warned of their increased risk for HPV and cervical cancer and, when appropriate, advised to undergo HPV vaccination.

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Linkage to HIV Care: To Give or Not to Give Financial Incentives?

Use of incentives makes the most sense with disadvantaged populations including homeless, drug users, and people in developing countries.

Role of the Microbiome on HIV Infection, Prevention, and Treatment

Role of the Microbiome on HIV Infection, Prevention, and Treatment

The interactions between HIV, ART, human sexual behavior, and the gut microbiome are complex and sorting out these interactions will be important to design future interventions.

Adolescents at Risk for HIV Should Be Offered PrEP

Adolescents at Risk for HIV Should Be Offered PrEP

Experts discuss new findings supporting the need for PrEP in adolescents and discuss the continued debate surrounding parental consent and other relevant issues.

Assessing the Risk Factors of Neurocognitive Decline in HIV+ Individuals

Assessing the Risk Factors of Neurocognitive Decline in HIV+ Individuals

The incidence of neurocognitive impairment is high in HIV-infected population, despite the introduction of combination antiretroviral therapy (CART).

Why Patients Discontinue ART— and What You Can Do to Stop It

Why Patients Discontinue ART— and What You Can Do to Stop It

Learn more about when stopping antiretroviral therapy (ART) may be necessary, why patients discontinue ART, predicting viral suppression, and predicting and encouraging adherence.

Slideshows

SIGN UP FOR FREE E-NEWSLETTERS